In the fight against infectious bacteria, humans are slowly losing the battle. That’s because common pathogens are developing resistance to the antibiotics we use to wipe them out. By 2050 it’s expected that, globally, drug-resistant infections will kill more people than cancer.
However, the fight is far from over. Researchers have discovered a potential new class of antibiotic that’s a triple threat: it obliterates many types of drug-resistant bacteria, it’s safe in mammals, and enemy ce